Hinde El Otmani/ISTH
Oct 16, 2025, 04:37
Hinde El Otmani’s Team Explores Plasmin-Mediated Proteolysis of von Willebrand Factor in Acutely Ill Patients
RPTH Journal shared on LinkedIn:
”Elevated von Willebrand factor (VWF) is common in liver disease, but its regulation remains unclear.
The latest study from Hinde El Otmani explores how plasmin-mediated VWF cleavage may lead to microvascular changes in acutely ill patients.
Check it out here.
Co-authors: Ton Lisman, Coen Maas, Marilena Stamouli, Jelle Adelmeijer”
Read the full article in RPTH.
Article: Plasmin-mediated proteolysis of von Willebrand factor in patients with acute and chronic liver disease
Authors: Hinde El Otmani, Marilena Stamouli, Jelle Adelmeijer, William Bernal, Coen Maas, Vishal C. Patel, Ton Lisman
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation
-
Jul 5, 2026, 20:22J. Meireles-Brandao: Exploring the Approach to Thrombophillias
-
Jul 5, 2026, 20:13Kavya Keerthana: The Platelet Count Everyone Calls ‘Reactive’ Until It Isn’t